|
|
|
|
| LEADER |
01715nmm a2200421 u 4500 |
| 001 |
EB000903235 |
| 003 |
EBX01000000000000000699131 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
141222 ||| eng |
| 020 |
|
|
|a 9780123820303
|
| 020 |
|
|
|a 0123820316
|
| 020 |
|
|
|a 0123820308
|
| 020 |
|
|
|a 9780123820310
|
| 100 |
1 |
|
|a Silverman, Richard B.
|
| 245 |
0 |
0 |
|a The organic chemistry of drug design and drug action
|h Elektronische Ressource
|
| 250 |
|
|
|a Third edition, Richard B. Silverman, Mark W. Holladay
|
| 260 |
|
|
|a San Diego, CA
|b Academic Press
|c 2014, [2014]
|
| 300 |
|
|
|a online resource
|
| 505 |
0 |
|
|a Includes bibliographical references and index
|
| 505 |
0 |
|
|a Introduction -- Lead discovery and lead modification -- Receptors -- Enzymes -- Enzyme inhibition and inactivation -- Dna-interactive agents -- Drug resistance and drug synergism -- Drug metabolism -- Prodrugs and drug delivery systems
|
| 653 |
|
|
|a Pharmaceutical chemistry
|
| 653 |
|
|
|a Pharmaceutical chemistry / fast / (OCoLC)fst01060115
|
| 653 |
|
|
|a Chemistry, Organic
|
| 653 |
|
|
|a Drugs / Design / fast / (OCoLC)fst00898790
|
| 653 |
|
|
|a Drug Design
|
| 653 |
|
|
|a Bioorganic chemistry / fast / (OCoLC)fst00832648
|
| 653 |
|
|
|a Pharmacokinetics
|
| 653 |
|
|
|a Chemistry, Pharmaceutical
|
| 653 |
|
|
|a Molecular pharmacology / fast / (OCoLC)fst01024822
|
| 653 |
|
|
|a Drugs / Design
|
| 653 |
|
|
|a Bioorganic chemistry
|
| 653 |
|
|
|a Molecular pharmacology
|
| 700 |
1 |
|
|a Holladay, Mark W.
|e [author]
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b ESD
|a Elsevier ScienceDirect eBooks
|
| 856 |
4 |
0 |
|u http://www.sciencedirect.com/science/book/9780123820303
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 615.1/9
|